3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylic acid

CAS : 104239-97-6

Ref. 3D-IO26684

Informations sur le produit

• Nom: 3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylic acid
• Synonymes: (4aR,4bS,6aS,7S,9aS,9bS,11aR)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-Tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-c arboxylic AcidDutasteride impurity A, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-Tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxylic acid, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-Carboxylic acid, (5alpha,17Beta)-3-OXO-4-Azaandrost-1-ene-17-Carboxylic acid, (5α,17β)-N-[(2,5-Bis(trifluoromethyl)-phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxylic acid, 1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-, 1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, [4aR-(4aα,4bβ,6aα,7α,9aβ,9bα,11aβ)]-, 3-Oxo-4-aza-5a-androst-1-ene-17-Carboxylic acid, 3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylicAcid, 3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylic acid, 4-Aza-5alpha-Androsta-1-en-3-One-17Beta-Carboxylic acid, 4-Aza-5Α-Androstan-1-Ene-3-Oxo-17Β-Carboxylic Acid, 4-Azaandrost-1-ene-17-carboxylic acid, 3-oxo-, (5α,17β)-, 4-Aza-5A-Androstan-1-ene-3-One-17β-Carboxylic acid

Description

3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylic acid is a covalently bonded prodrug that is metabolized to its active form, finasteride, in the body. It has been shown to have physiological activities such as skin permeation and cell growth. 3-Oxo-4-aza-5a-androst-1-ene 17b carboxylic acid also has immunotherapy properties and can be conjugated with other compounds for use in cancer treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 317.42 g/mol
• Formule: C₁₉H₂₇NO₃
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder